Impairment in the Nrf2/HO-1 pathway has been reported in several ocular diseases, such as uveitis, cataracts, glaucoma, diabetic retinopathy, age-related macular degeneration (AMD), and RGC damage [30,31]. Here, NFE2L2 is linked to diabetic retinopathy.